The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
The launch comes against the backdrop of a significant public health burden
The approval marks a major milestone in the global fight against antimicrobial resistance
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Transition to a fermentation-based globally integrated CDMO platform
Subscribe To Our Newsletter & Stay Updated
